DK1871380T3 - Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser - Google Patents

Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser

Info

Publication number
DK1871380T3
DK1871380T3 DK06731937.6T DK06731937T DK1871380T3 DK 1871380 T3 DK1871380 T3 DK 1871380T3 DK 06731937 T DK06731937 T DK 06731937T DK 1871380 T3 DK1871380 T3 DK 1871380T3
Authority
DK
Denmark
Prior art keywords
treatment
combined use
proton pump
gastrointestinal disorders
pump inhibitor
Prior art date
Application number
DK06731937.6T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of DK1871380T3 publication Critical patent/DK1871380T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06731937.6T 2005-04-12 2006-04-11 Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser DK1871380T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67023805P 2005-04-12 2005-04-12
PCT/JP2006/308001 WO2006109881A1 (en) 2005-04-12 2006-04-11 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
DK1871380T3 true DK1871380T3 (da) 2011-11-21

Family

ID=36685683

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06731937.6T DK1871380T3 (da) 2005-04-12 2006-04-11 Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser

Country Status (18)

Country Link
US (1) US8962688B2 (cg-RX-API-DMAC7.html)
EP (1) EP1871380B1 (cg-RX-API-DMAC7.html)
JP (2) JP5711442B2 (cg-RX-API-DMAC7.html)
KR (2) KR20140069182A (cg-RX-API-DMAC7.html)
CN (1) CN101198334B (cg-RX-API-DMAC7.html)
AU (1) AU2006234632B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0610557A2 (cg-RX-API-DMAC7.html)
CA (1) CA2602812C (cg-RX-API-DMAC7.html)
DK (1) DK1871380T3 (cg-RX-API-DMAC7.html)
ES (1) ES2371658T3 (cg-RX-API-DMAC7.html)
IL (1) IL186374A (cg-RX-API-DMAC7.html)
NO (1) NO20075764L (cg-RX-API-DMAC7.html)
NZ (1) NZ562763A (cg-RX-API-DMAC7.html)
PL (1) PL1871380T3 (cg-RX-API-DMAC7.html)
PT (1) PT1871380E (cg-RX-API-DMAC7.html)
RU (1) RU2468800C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006109881A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200709072B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1562604E (pt) * 2002-10-23 2012-04-09 Sucampo Ag Compostos de prostaglandina para o tratamento de obesidade
JP5427029B2 (ja) * 2006-09-06 2014-02-26 スキャンポ・アーゲー 消化管の重炭酸分泌を促進するための方法および組成物
US20090012165A1 (en) * 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
WO2009157397A1 (ja) * 2008-06-23 2009-12-30 日本新薬株式会社 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
CN103781482A (zh) * 2011-04-19 2014-05-07 苏坎波公司 用于调节细胞因子活性的方法
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
KR20160015100A (ko) 2014-07-30 2016-02-12 미래파인켐 주식회사 프로스타글란딘 중간체의 제조방법
KR20170025682A (ko) 2015-08-31 2017-03-08 미래파인켐 주식회사 프로스타글란딘 유도체의 신규한 제조방법
CN107582556A (zh) * 2017-09-15 2018-01-16 成都泠汐尚品科技有限公司 一种治疗消化性溃疡的药物复方制剂
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
JPH0688966B2 (ja) * 1987-01-28 1994-11-09 株式会社アールテック・ウエノ プロスタグランジンｅ類およびそれを含む抗潰瘍剤
US5380709A (en) * 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5225439A (en) * 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5221763A (en) * 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
TW249226B (cg-RX-API-DMAC7.html) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
WO1997047595A1 (en) * 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
SE9804314D0 (sv) * 1998-12-14 1998-12-14 Astra Ab New pharmaceutical formulation
JP4332316B2 (ja) * 1999-10-15 2009-09-16 スキャンポ・アーゲー 二環式化合物組成物およびその安定化方法
AU4472701A (en) * 2000-04-06 2001-10-23 Sucampo Ag Bile secretion promoting composition
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
BR0212233A (pt) * 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
KR101164838B1 (ko) * 2002-12-27 2012-07-11 수캄포 아게 복부 불쾌감 치료용 프로스타글랜딘의 유도체
JP2006516562A (ja) * 2003-01-24 2006-07-06 ステート オブ イスラエル、ミニストリー オブ アグリカルチャー 抗酸化活性を増強するための相乗的な組成物及び方法
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物

Also Published As

Publication number Publication date
JP2013121972A (ja) 2013-06-20
NZ562763A (en) 2010-12-24
CA2602812A1 (en) 2006-10-19
KR20070119753A (ko) 2007-12-20
KR20140069182A (ko) 2014-06-09
IL186374A (en) 2013-05-30
PT1871380E (pt) 2011-11-21
CA2602812C (en) 2014-11-18
WO2006109881A1 (en) 2006-10-19
EP1871380A1 (en) 2008-01-02
BRPI0610557A2 (pt) 2010-06-29
EP1871380B1 (en) 2011-10-19
US8962688B2 (en) 2015-02-24
RU2007141655A (ru) 2009-05-20
AU2006234632B2 (en) 2011-10-27
KR101466980B1 (ko) 2014-12-01
ES2371658T3 (es) 2012-01-05
NO20075764L (no) 2008-01-14
RU2468800C2 (ru) 2012-12-10
US20070276006A1 (en) 2007-11-29
CN101198334B (zh) 2013-02-06
PL1871380T3 (pl) 2012-03-30
JP5711442B2 (ja) 2015-04-30
IL186374A0 (en) 2008-03-20
JP2008535774A (ja) 2008-09-04
ZA200709072B (en) 2008-11-26
AU2006234632A1 (en) 2006-10-19
CN101198334A (zh) 2008-06-11

Similar Documents

Publication Publication Date Title
DK1942898T4 (da) Dipeptidylpeptidase-inhibitorer til behandling af diabetes
CY2014012I2 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
PL1636190T3 (pl) Trwały kryształ związku 4-oksochinoliny
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
ZA200709072B (en) Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK2356093T3 (da) Carbazolforbindelser og terapeutiske anvendelser af forbindelserne
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK2653873T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK1586319T3 (da) Thiadiazolidinoner som GSK-3-inhibitorer
IS8550A (is) Imídasól efnasambönd til meðhöndlunar á taugahrörnunarsjúkdómum
DK1996557T3 (da) Pyridazinon-forbindelse og anvendelse deraf som herbicid
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
LTC1912640I2 (lt) HDAC inhibitoriaus panobinostato panaudojimas mielomos gydymui
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
DK1701944T3 (da) 2-(amino-substituerede)-4-aryl-pyramidiner og relaterede forbindelser til behandling af inflammationssygdomme
DK1959988T3 (da) Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder
DK1801108T3 (da) Morpholinforbindelser til behandling af inflammationer.
DK1896077T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
PL1763520T3 (pl) Zastosowanie tripodstawionych benzopiranonów